{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:28:30Z","timestamp":1788272910654,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH Intramural Program"],"award-info":[{"award-number":["NIH Intramural Program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pathogenic variants in BRCA2 are known to significantly increase the lifetime risk of developing breast and ovarian cancers. Sequencing-based genetic testing has resulted in the identification of thousands of BRCA2 variants that are considered to be variants of uncertain significance (VUS) because the disease risk associated with them is unknown. One such variant is p.Arg3052Gln, which has conflicting interpretations of pathogenicity in the ClinVar variant database. Arginine at position 3052 in BRCA2 plays an important role in stabilizing its C-terminal DNA binding domain. We have generated a knock-in mouse model expressing this variant to examine its role on growth and survival in vivo. Homozygous as well as hemizygous mutant mice are viable, fertile and exhibit no overt phenotype. While we did not observe any hematopoietic defects in adults, we did observe a marked reduction in the in vitro proliferative ability of fetal liver cells that were also hypersensitive to PARP inhibitor, olaparib. In vitro studies performed on embryonic and adult fibroblasts derived from the mutant mice showed significant reduction in radiation induced RAD51 foci formation as well as increased genomic instability after mitomycin C treatment. We observed mis-localization of a fraction of R3052Q BRCA2 protein to the cytoplasm which may explain the observed in vitro phenotypes. Our findings suggest that BRCA2 R3052Q should be considered as a hypomorphic variant.<\/jats:p>","DOI":"10.1038\/s41419-023-06289-8","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:03:11Z","timestamp":1700298191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of BRCA2 R3052Q variant in mice supports its functional impact as a low-risk variant"],"prefix":"10.1038","volume":"14","author":[{"given":"Arun Prakash","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8816-8585","authenticated-orcid":false,"given":"Suzanne","family":"Hartford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajani Kant","family":"Chittela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-6651","authenticated-orcid":false,"given":"Sounak","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-7429","authenticated-orcid":false,"given":"Suhas S.","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Alvaro-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Contreras-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Albaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Southon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-4028","authenticated-orcid":false,"given":"Sandra","family":"Burkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktiar","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-772X","authenticated-orcid":false,"given":"Lino","family":"Tessarollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-870X","authenticated-orcid":false,"given":"Shyam K.","family":"Sharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"6289_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA."},{"key":"6289_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/genes12050780","volume":"12","author":"J Jimenez-Sainz","year":"2021","unstructured":"Jimenez-Sainz J, Jensen RB. Imprecise medicine: BRCA2 variants of uncertain significance (VUS), the challenges and benefits to integrate a functional assay workflow with clinical decision rules. Genes. 2021;12:780.","journal-title":"Genes"},{"key":"6289_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/humu.22478","volume":"35","author":"L Guidugli","year":"2014","unstructured":"Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro ANA, et al. Functional assays for analysis of variants of uncertain significance in BRCA2. Hum Mutat. 2014;35:151\u201364.","journal-title":"Hum Mutat"},{"key":"6289_CR4","doi-asserted-by":"publisher","first-page":"CIN.S618","DOI":"10.4137\/CIN.S618","volume":"6","author":"R Karchin","year":"2008","unstructured":"Karchin R, Agarwal M, Sali A, Couch F, Beattie MS. Classifying variants of undetermined significance in BRCA2 with protein likelihood ratios. Cancer Inf. 2008;6:CIN.S618.","journal-title":"Cancer Inf"},{"key":"6289_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979\u201393.","journal-title":"Cell."},{"key":"6289_CR6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cell.2017.05.010","volume":"169","author":"SLW Tan","year":"2017","unstructured":"Tan SLW, Chadha S, Liu Y, Gabasova E, Perera D, Ahmed K, et al. A class of environmental and endogenous toxins induces BRCA2 haploinsufficiency and genome instability. Cell. 2017;169:1105\u201318.e15.","journal-title":"Cell"},{"key":"6289_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/sj.onc.1209153","volume":"25","author":"J Li","year":"2006","unstructured":"Li J, Zou C, Bai Y, Wazer DE, Band V, Gao Q. DSS1 is required for the stability of BRCA2. Oncogene. 2006;25:1186\u201394.","journal-title":"Oncogene"},{"key":"6289_CR8","doi-asserted-by":"publisher","first-page":"e1002409.","DOI":"10.1371\/journal.pgen.1002409","volume":"7","author":"N Siaud","year":"2011","unstructured":"Siaud N, Barbera MA, Egashira A, Lam I, Christ N, Schlacher K. Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains. PLoS Genet. 2011;7:e1002409.","journal-title":"PLoS Genet"},{"key":"6289_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nsmb.2666","volume":"20","author":"AD Jeyasekharan","year":"2013","unstructured":"Jeyasekharan AD, Liu Y, Hattori H, Pisupati V, Jonsdottir AB, Rajendra E, et al. A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. Nat Struct Mol Biol. 2013;20:1191\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"6289_CR10","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1093\/nar\/gkab308","volume":"49","author":"M Lee","year":"2021","unstructured":"Lee M, Shorthouse D, Mahen R, Hall BA, Venkitaraman AR. Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance. Nucleic Acids Res. 2021;49:5588\u2013604.","journal-title":"Nucleic Acids Res"},{"key":"6289_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29409-y","volume":"13","author":"AP Mishra","year":"2022","unstructured":"Mishra AP, Hartford SA, Sahu S, Klarmann K, Chittela RK, Biswas K, et al. BRCA2-DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks. Nat Commun. 2022;13:1751.","journal-title":"Nat Commun"},{"key":"6289_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","volume":"297","author":"H Yang","year":"2002","unstructured":"Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thom\u00e4 NH, et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 2002;297:1837\u201348.","journal-title":"Science"},{"key":"6289_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1097-2765(01)00175-7","volume":"7","author":"AA Davies","year":"2001","unstructured":"Davies AA, Masson J-Y, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR, et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell. 2001;7:273\u201382.","journal-title":"Mol Cell"},{"key":"6289_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","volume":"145","author":"K Schlacher","year":"2011","unstructured":"Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell. 2011;145:529\u201342.","journal-title":"Cell"},{"key":"6289_CR15","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/humu.23818","volume":"40","author":"MT Parsons","year":"2019","unstructured":"Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadal\u00f3 L, et al. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification. Hum Mutat. 2019;40:1557\u201378.","journal-title":"Hum Mutat"},{"key":"6289_CR16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1073\/pnas.71.4.1250","volume":"71","author":"R Jaenisch","year":"1974","unstructured":"Jaenisch R, Mintz B. Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc Natl Acad Sci USA. 1974;71:1250\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6289_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/oxfordjournals.jhered.a108361","volume":"64","author":"DJ Nash","year":"1973","unstructured":"Nash DJ, Kidwell JF. A genetic analysis of lifespan, fecundity, and weight in the mouse. J Hered. 1973;64:87\u201390.","journal-title":"J Hered"},{"key":"6289_CR18","doi-asserted-by":"publisher","first-page":"e1010940","DOI":"10.1371\/journal.pgen.1010940","volume":"19","author":"S Sahu","year":"2023","unstructured":"Sahu S, Sullivan TL, Mitrophanov AY, Galloux M, Nousome D, Southon E, et al. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. PLoS Genet. 2023;19:e1010940.","journal-title":"PLoS Genet"},{"key":"6289_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm.1719","volume":"14","author":"SG Kuznetsov","year":"2008","unstructured":"Kuznetsov SG, Liu P, Sharan SK. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med. 2008;14:875\u201381.","journal-title":"Nat Med"},{"key":"6289_CR20","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1158\/0008-5472.CAN-07-1587","volume":"68","author":"DJ Farrugia","year":"2008","unstructured":"Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh AM, Pruss D, Frye C, et al. Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res. 2008;68:3523\u201331.","journal-title":"Cancer Res"},{"key":"6289_CR21","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-16-2568","volume":"77","author":"H Shimelis","year":"2017","unstructured":"Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017;77:2789\u201399.","journal-title":"Cancer Res"},{"key":"6289_CR22","doi-asserted-by":"publisher","first-page":"884210","DOI":"10.3389\/fgene.2022.884210","volume":"13","author":"J Jimenez-Sainz","year":"2022","unstructured":"Jimenez-Sainz J, Krysztofiak A, Garbarino J, Rogers F, Jensen RB. The pathogenic R3052W BRCA2 variant disrupts homology-directed repair by failing to localize to the nucleus. Front Genet. 2022;13:884210.","journal-title":"Front Genet"},{"key":"6289_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-211","volume":"9","author":"L Mohammadi","year":"2009","unstructured":"Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, et al. A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer. 2009;9:211.","journal-title":"BMC Cancer"},{"key":"6289_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2223","volume":"11","author":"EB G\u00f3mez Garc\u00eda","year":"2009","unstructured":"G\u00f3mez Garc\u00eda EB, Oosterwijk JC, Timmermans M, van Asperen CJ, Hogervorst FBL, Hoogerbrugge N, et al. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. Breast Cancer Res. 2009;11:R8.","journal-title":"Breast Cancer Res"},{"key":"6289_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1006236","volume":"12","author":"SA Hartford","year":"2016","unstructured":"Hartford SA, Chittela R, Ding X, Vyas A, Martin B, Burkett S, et al. Interaction with PALB2 is essential for maintenance of genomic integrity by BRCA2. PLoS Genet. 2016;12:1\u201327.","journal-title":"PLoS Genet"},{"key":"6289_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/386804a0","volume":"386","author":"SK Sharan","year":"1997","unstructured":"Sharan SK, Morimatsu M, Albrecht U, Lim D-S, Regel E, Dinh C, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 1997;386:804\u201310.","journal-title":"Nature"},{"key":"6289_CR27","doi-asserted-by":"crossref","unstructured":"Ehmsen KT, Heyer W-D. Biochemistry of meiotic recombination: formation, processing, and resolution of recombination intermediates. In: Egel R, Lankenau D-H, editors. Recombination and meiosis: models, means, and evolution. Berlin, Heidelberg: Springer; 2008. p. 91\u2013164.","DOI":"10.1007\/7050_2008_039"},{"key":"6289_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10911-017-9372-0","volume":"22","author":"IS Paine","year":"2017","unstructured":"Paine IS, Lewis MT. The terminal end bud: the little engine that could. J Mammary Gland Biol Neoplasia. 2017;22:93\u2013108.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"6289_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11224-6","volume":"12","author":"S Sahu","year":"2022","unstructured":"Sahu S, Albaugh ME, Martin BK, Patel NL, Riffle L, Mackem S, et al. Growth factor dependency in mammary organoids regulates ductal morphogenesis during organ regeneration. Sci Rep. 2022;12:7200.","journal-title":"Sci Rep"},{"key":"6289_CR30","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1093\/nar\/gkh703","volume":"32","author":"N Saleh-Gohari","year":"2004","unstructured":"Saleh-Gohari N, Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res. 2004;32:3683\u20138.","journal-title":"Nucleic Acids Res"},{"key":"6289_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molcel.2020.04.006","volume":"78","author":"J Nacson","year":"2020","unstructured":"Nacson J, Di Marcantonio D, Wang Y, Bernhardy AJ, Clausen E, Hua X, et al. BRCA1 mutational complementation induces synthetic viability. Mol Cell. 2020;78:951\u20139.e6.","journal-title":"Mol Cell"},{"key":"6289_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1158\/0008-5472.CAN-12-2081","volume":"73","author":"L Guidugli","year":"2013","unstructured":"Guidugli L, Pankratz VS, Singh N, Thompson J, Erding CA, Engel C, et al. A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res. 2013;73:265\u201375.","journal-title":"Cancer Res"},{"key":"6289_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41436-018-0052-2","volume":"21","author":"RLS Mesman","year":"2019","unstructured":"Mesman RLS, Call\u00e9ja FMGR, Hendriks G, Morolli B, Misovic B, Devilee P, et al. The functional impact of variants of uncertain significance in BRCA2. Genet Med. 2019;21:293\u2013302.","journal-title":"Genet Med"},{"key":"6289_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.","journal-title":"Nat Commun"},{"key":"6289_CR35","doi-asserted-by":"publisher","first-page":"3895.","DOI":"10.3390\/ijms21113895","volume":"21","author":"Y Hirotsu","year":"2020","unstructured":"Hirotsu Y, Schmidt-Edelkraut U, Nakagomi H, Sakamoto I, Hartenfeller M, Narang R. et al. Consolidated BRCA1\/2 variant interpretation by MH BRCA correlates with predicted PARP inhibitor efficacy association by MH guide. Int J Mol Sci. 2020;21:3895.","journal-title":"Int J Mol Sci"},{"key":"6289_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36149-0","volume":"14","author":"D Vugic","year":"2023","unstructured":"Vugic D, Dumoulin I, Martin C, Minello A, Alvaro-Aranda L, Gomez-Escudero J, et al. Replication gap suppression depends on the double-strand DNA binding activity of BRCA2. Nat Commun. 2023;14:446.","journal-title":"Nat Commun"},{"key":"6289_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-59745-471-1_9","volume":"530","author":"E Southon","year":"2009","unstructured":"Southon E, Tessarollo L. Manipulating mouse embryonic stem cells. Methods Mol Biol. 2009;530:165\u201385.","journal-title":"Methods Mol Biol"},{"key":"6289_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-61779-564-0_10","volume":"852","author":"K Biswas","year":"2012","unstructured":"Biswas K, Stauffer S, Sharan SK. Using recombineering to generate point mutations: galK-based positive-negative selection method. Methods Mol Biol. 2012;852:121\u201331.","journal-title":"Methods Mol Biol"},{"key":"6289_CR39","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/gni035","volume":"33","author":"S Warming","year":"2005","unstructured":"Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 2005;33:e36.","journal-title":"Nucleic Acids Res"},{"key":"6289_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/geno.2000.6451","volume":"73","author":"EC Lee","year":"2001","unstructured":"Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001;73:56\u201365.","journal-title":"Genomics"},{"key":"6289_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng0298-136","volume":"18","author":"EN Meyers","year":"1998","unstructured":"Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet. 1998;18:136\u201341.","journal-title":"Nat Genet"},{"key":"6289_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/geno.1996.4573","volume":"40","author":"SK Sharan","year":"1997","unstructured":"Sharan SK, Bradley A. Murine Brca2: sequence, map position, and expression pattern. Genomics. 1997;40:234\u201341.","journal-title":"Genomics"},{"key":"6289_CR43","first-page":"e55378.","volume":"129","author":"F Dia","year":"2017","unstructured":"Dia F, Strange T, Liang J, Hamilton J, Berkowitz KM. Preparation of meiotic chromosome spreads from mouse spermatocytes. J Vis Exp. 2017;129:e55378.","journal-title":"J Vis Exp"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06289-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:05:54Z","timestamp":1700337954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06289-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["6289"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06289-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"753"}}